
Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Fierce editors discuss a rough day for Valeant Pharmaceuticals and Biogen, plus the changing in winds in biotech venture capital.
Doomsdays for Valeant, Biogen and biotech VC is an episode from FierceBiotech Radio. Fierce editors discuss a rough day for Valeant Pharmaceuticals and Biogen, plus the changing in winds in biotech venture capital. The episode was published...
This episode belongs to FierceBiotech Radio.
Use the player on this page to stream the episode online.
Published Oct 22, 2015, 21:50 long, audio available.
Fierce editors discuss a rough day for Valeant Pharmaceuticals and Biogen, plus the changing in winds in biotech venture capital.
You can listen to Doomsdays for Valeant, Biogen and biotech VC online on Radio and Podcast. Open the player on this page to stream the available audio.
Doomsdays for Valeant, Biogen and biotech VC is an episode from FierceBiotech Radio.
This episode is 21:50 long.
This episode was published on Oct 22, 2015.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from FierceBiotech Radio when more episodes are available from the podcast feed.
You can listen to Doomsdays for Valeant, Biogen and biotech VC on this page when the episode audio is available from the podcast feed.
Doomsdays for Valeant, Biogen and biotech VC is from FierceBiotech Radio.
Published Oct 22, 2015 and 21:50 long